VIR | Vir Biotechnology, Inc.

Index- P/E- EPS (ttm)-1.10 Insider Own1.70% Shs Outstand133.55M Perf Week-0.22%
Market Cap3.53B Forward P/E- EPS next Y-4.91 Insider Trans-63.97% Shs Float114.86M Perf Month6.00%
Income-143.70M PEG- EPS next Q-1.20 Inst Own76.10% Short Float / Ratio4.40% / 5.44 Perf Quarter18.01%
Sales446.30M P/S7.92 EPS this Y-3.40% Inst Trans-5.43% Short Interest5.05M Perf Half Y-1.04%
Book/sh14.76 P/B1.81 EPS next Y-18.30% ROA-5.30% Target Price49.71 Perf Year-0.11%
Cash/sh16.98 P/C1.57 EPS next 5Y7.00% ROE-7.10% 52W Range18.05 - 31.78 Perf YTD5.37%
Dividend- P/FCF3.81 EPS past 5Y92.00% ROI28.60% 52W High-16.08% Beta0.26
Dividend %- Quick Ratio4.90 Sales past 5Y259.00% Gross Margin87.00% 52W Low47.76% ATR0.95
Employees576 Current Ratio4.90 Sales Q/Q-94.90% Oper. Margin- RSI (14)62.04 Volatility4.24% 4.01%
OptionableYes Debt/Eq0.00 EPS Q/Q-127.40% Profit Margin-32.20% Rel Volume0.00 Prev Close26.67
ShortableYes LT Debt/Eq0.00 EarningsMay 04 AMC Payout0.00% Avg Volume928.59K Price26.67
Recom1.90 SMA205.43% SMA508.89% SMA2008.71% Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Mar-06-23Upgrade JP Morgan Neutral → Overweight $35 → $34
Feb-21-23Upgrade Goldman Neutral → Buy $41 → $53
Jan-27-23Upgrade Morgan Stanley Underweight → Equal-Weight $18 → $30
Sep-14-22Initiated SVB Leerink Outperform $40
Sep-09-22Initiated Morgan Stanley Underweight $15
Mar-03-22Upgrade Robert W. Baird Underperform → Neutral $36 → $28
Dec-21-21Downgrade Robert W. Baird Neutral → Underperform $36
Oct-25-21Upgrade JP Morgan Underweight → Neutral $29 → $37
Sep-22-21Downgrade Goldman Buy → Neutral $64 → $62
Jun-04-21Resumed Robert W. Baird Neutral $45
May-17-23 04:05PM
May-16-23 09:25AM
May-15-23 08:35AM
08:00AM
May-11-23 08:30AM
02:07PM Loading…
May-10-23 02:07PM
May-04-23 07:45PM
05:48PM
04:05PM
May-03-23 04:05PM
May-02-23 09:00AM
Apr-28-23 10:00AM
Apr-27-23 10:03AM
Apr-26-23 08:00PM
Apr-11-23 04:05PM
01:40PM Loading…
Apr-05-23 01:40PM
Mar-29-23 08:40AM
Mar-21-23 02:33PM
Mar-08-23 04:05PM
Mar-05-23 07:30AM
Mar-03-23 06:57PM
Feb-28-23 04:05PM
Feb-26-23 07:13AM
Feb-23-23 05:35PM
04:05PM
Feb-22-23 08:30AM
Feb-20-23 10:00AM
Feb-16-23 04:05PM
10:01AM
08:30AM
04:33PM Loading…
Feb-14-23 04:33PM
08:19AM
Feb-13-23 04:45PM
Feb-02-23 02:19PM
Jan-31-23 10:06AM
Jan-25-23 06:05PM
08:29AM
Jan-24-23 12:00PM
Jan-22-23 07:15AM
Jan-21-23 04:51PM
07:36AM
Jan-20-23 09:40AM
Jan-03-23 04:05PM
Dec-31-22 08:44AM
Dec-22-22 05:30PM
Dec-21-22 08:00AM
Dec-06-22 06:04AM
Dec-02-22 07:10AM
Nov-24-22 09:55AM
Nov-22-22 09:40AM
Nov-17-22 04:48PM
04:48PM
09:15AM
Nov-16-22 08:30AM
Nov-09-22 05:32AM
Nov-08-22 09:55AM
09:40AM
Nov-07-22 08:57AM
Nov-06-22 10:35AM
Nov-05-22 08:18AM
Nov-04-22 05:46PM
04:16PM
Nov-03-22 06:05PM
04:03PM
Oct-31-22 07:20PM
04:05PM
Oct-28-22 06:06PM
Oct-18-22 08:32AM
08:00AM
Oct-12-22 01:27PM
Oct-11-22 04:03PM
Oct-07-22 12:33PM
Oct-05-22 09:37AM
Oct-04-22 12:56PM
09:01AM
08:00AM
08:00AM
Sep-22-22 08:00AM
Sep-20-22 09:16PM
Sep-16-22 03:49PM
Sep-14-22 02:11PM
08:56AM
Sep-06-22 04:05PM
Aug-10-22 07:35AM
Aug-09-22 06:05PM
04:02PM
Aug-01-22 10:01AM
Jul-31-22 09:00AM
Jul-30-22 06:15AM
Jul-28-22 10:03AM
Jul-21-22 04:05PM
Jul-14-22 08:30AM
Jul-12-22 11:30AM
Jul-06-22 02:22PM
Jul-05-22 06:32AM
Jun-27-22 10:47AM
Jun-25-22 07:00AM
Jun-19-22 11:25AM
Jun-08-22 07:34AM
Jun-06-22 01:20PM
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. The company was incorporated in 2016 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SVF Endurance (Cayman) Ltd10% OwnerMay 24Sale26.15104,3842,729,59917,178,585May 25 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerMay 23Sale26.66170,0674,533,23017,282,969May 25 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerMay 22Sale25.7291,8962,363,90517,453,036May 23 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerMay 19Sale25.3891,6512,326,23117,544,932May 23 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerMay 05Sale25.101363,41417,636,583May 09 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerMay 04Sale25.55114,3322,921,16017,636,719May 05 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerMay 03Sale25.5183,6742,134,69117,751,051May 05 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerMay 01Sale25.303,07577,81217,834,725May 03 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerApr 25Sale25.3096124,31317,837,800Apr 26 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerApr 24Sale25.4266,0381,678,63317,838,761Apr 26 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerApr 21Sale25.78305,3937,872,24717,904,799Apr 24 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerApr 20Sale25.066,590165,14718,210,192Apr 24 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerApr 19Sale25.1276,1141,911,96818,216,782Apr 20 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerApr 18Sale25.126,953174,66118,292,896Apr 20 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerApr 17Sale25.0610,524263,74118,299,849Apr 18 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerApr 14Sale25.119,565240,15218,310,373Apr 18 09:00 PM
HANLY ANN M.Chief Technology OfficerMar 30Sale22.772,62759,817114,576Mar 31 02:40 PM
SATO VICKI LDirectorMar 08Sale22.5917,935405,0621,327,324Mar 09 02:36 PM
Friedl-Naderer JohannaEVP & Chief Operating OfficerMar 03Sale22.821,48233,819148,518Mar 07 02:04 PM
Sigal Charles ElliottDirectorMar 01Buy22.732,50056,81610,000Mar 02 04:27 PM
SCANGOS GEORGE APresident and CEOFeb 24Sale23.3315,119352,682168,489Feb 24 08:34 PM
SCANGOS GEORGE APresident and CEOFeb 23Sale25.9712,631328,065183,608Feb 24 08:34 PM
Pang PhillipChief Medical OfficerFeb 23Sale25.972,87874,750198,320Feb 24 08:29 PM
HANLY ANN M.Chief Technology OfficerFeb 23Sale25.972,30259,790117,203Feb 24 08:35 PM
Horn HowardCFOFeb 23Sale25.972,24858,387230,712Feb 24 08:36 PM
Rice Steven J.Chief Administrative OfficerFeb 23Sale25.971,79546,622108,414Feb 24 08:28 PM
SVF Endurance (Cayman) Ltd10% OwnerFeb 21Sale28.4374,4772,117,33618,319,938Feb 23 09:00 PM
SCANGOS GEORGE APresident and CEOFeb 21Sale28.3017,856505,318196,239Feb 21 07:29 PM
SCANGOS GEORGE APresident and CEOFeb 17Sale25.299,894250,199214,095Feb 21 07:29 PM
Pang PhillipChief Medical OfficerFeb 17Sale25.292,80270,857141,198Feb 21 07:24 PM
Horn HowardCFOFeb 17Sale25.292,42461,298232,960Feb 21 07:22 PM
Rice Steven J.Chief Administrative OfficerFeb 17Sale25.291,98150,09637,209Feb 21 07:25 PM
SVF Endurance (Cayman) Ltd10% OwnerFeb 15Sale26.7538,9641,042,38418,394,415Feb 17 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerFeb 14Sale26.8138,9071,043,10818,433,379Feb 15 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerFeb 13Sale26.0279,0502,056,58518,472,286Feb 15 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerFeb 10Sale26.1397,2212,540,30018,551,336Feb 13 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerFeb 09Sale26.38137,0503,615,72918,648,557Feb 13 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerFeb 08Sale27.8881,9142,284,15318,785,607Feb 09 09:00 PM
SATO VICKI LDirectorFeb 08Sale28.3817,915508,3431,345,259Feb 09 11:27 AM
SVF Endurance (Cayman) Ltd10% OwnerFeb 07Sale29.3363,5081,862,39618,867,521Feb 09 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerFeb 06Sale29.9245,2491,353,84918,931,029Feb 07 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerFeb 03Sale30.4068,7862,091,13518,976,278Feb 07 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerFeb 02Sale29.7086,8012,578,01619,045,064Feb 03 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerFeb 01Sale29.0261,8341,794,15919,131,865Feb 03 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 31Sale29.4773,8832,177,23219,193,699Feb 01 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 30Sale29.4678,9302,325,10619,267,582Feb 01 09:00 PM
Pang PhillipChief Medical OfficerJan 24Sale30.0030,000900,057144,000Jan 25 08:01 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 23Sale28.3436,5121,034,70719,346,512Jan 25 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 20Sale27.41144,3583,956,80119,383,024Jan 23 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 19Sale26.5669,8391,854,61019,527,382Jan 23 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 18Sale26.31102,4672,696,40919,597,221Jan 19 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 17Sale26.2488,3722,318,74919,699,688Jan 19 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 13Sale26.5494,1992,499,74919,788,060Jan 17 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 12Sale26.61117,4793,126,12919,882,259Jan 17 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 11Sale26.2479,0652,074,60719,999,738Jan 12 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 10Sale26.4170,5751,863,88620,078,803Jan 12 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 09Sale25.8534,801899,57420,149,378Jan 10 09:00 PM
SATO VICKI LDirectorJan 09Sale25.8317,915462,7841,363,174Jan 11 11:40 AM
SVF Endurance (Cayman) Ltd10% OwnerJan 06Sale26.1366,1791,729,39920,184,179Jan 10 09:00 PM
Sigal Charles ElliottDirectorJan 05Buy24.962,50062,3967,500Jan 09 11:51 AM
Sigal Charles ElliottDirectorJan 04Buy25.252,50063,1365,000Jan 05 05:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 04Sale25.471,00025,46820,250,358Jan 05 09:00 PM
Sigal Charles ElliottDirectorJan 03Buy25.602,50063,9922,500Jan 05 05:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJan 03Sale25.588,177209,14520,251,358Jan 05 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerDec 29Sale25.5544,1691,128,46120,259,535Jan 03 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerDec 27Sale25.596,850175,30420,303,704Dec 29 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerDec 23Sale25.7680,0812,063,11520,310,554Dec 27 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerDec 22Sale26.0795,1442,480,39920,390,635Dec 27 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerDec 21Sale26.13111,7302,919,29120,485,779Dec 22 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerDec 20Sale25.53104,0262,656,29420,597,509Dec 22 09:00 PM
SATO VICKI LDirectorDec 08Sale25.8117,915462,3661,381,089Dec 09 03:43 PM
SVF Endurance (Cayman) Ltd10% OwnerDec 05Sale27.258,831240,64420,701,535Dec 06 09:30 PM
SVF Endurance (Cayman) Ltd10% OwnerDec 02Sale27.4788,4622,430,41420,710,366Dec 06 09:30 PM
SVF Endurance (Cayman) Ltd10% OwnerDec 01Sale27.4846,3761,274,33420,798,828Dec 02 05:51 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 30Sale27.85165,9534,621,60720,845,204Dec 02 05:51 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 29Sale27.3971,1261,948,20521,011,157Nov 30 08:50 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 28Sale27.4637,9891,043,18021,082,283Nov 30 08:50 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 25Sale27.2117,264469,67121,120,272Nov 28 05:04 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 23Sale27.3039,7291,084,74521,137,536Nov 28 05:04 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 22Sale27.2765,2131,778,19521,177,265Nov 23 04:30 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 21Sale27.1372019,53521,242,478Nov 22 06:00 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 18Sale27.2125,259687,28221,243,198Nov 22 06:00 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 17Sale27.1873,0301,984,70021,268,457Nov 18 04:30 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 16Sale27.54137,0013,772,90921,341,487Nov 18 04:30 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 15Sale27.7287,8002,434,04621,478,488Nov 16 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 14Sale27.4150,1731,375,22221,566,288Nov 16 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 11Sale27.27159,3544,346,04621,616,461Nov 14 04:31 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 10Sale27.35123,1133,367,30121,775,815Nov 14 04:31 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 09Sale27.215,269143,39221,898,928Nov 14 04:31 PM
SVF Endurance (Cayman) Ltd10% OwnerNov 08Sale27.3849,1051,344,40721,904,197Nov 09 04:30 PM
SATO VICKI LDirectorNov 08Sale27.3817,915490,5491,399,004Nov 09 11:09 AM
SVF Endurance (Cayman) Ltd10% OwnerNov 07Sale27.22132,9783,619,67421,953,302Nov 09 04:30 PM
SATO VICKI LDirectorOct 10Sale20.6717,915370,2781,416,919Oct 11 01:12 PM
SATO VICKI LDirectorSep 08Sale21.9017,915392,3351,434,834Sep 09 01:47 PM
SVF Endurance (Cayman) Ltd10% OwnerAug 16Sale27.647,800215,61422,086,280Aug 17 04:53 PM
SVF Endurance (Cayman) Ltd10% OwnerAug 15Sale27.99122,5643,430,14422,094,080Aug 17 04:53 PM
Virgin HerbertEVP, Research & CSOAug 09Option Exercise2.4378,093189,658262,500Aug 10 04:50 PM
Pang PhillipChief Medical OfficerJul 20Sale30.005,000150,000144,000Jul 21 04:10 PM
Ramasastry SairaDirectorJul 11Sale30.005,000150,0008,092Jul 13 04:05 PM
SATO VICKI LDirectorJul 08Sale29.0617,915520,6941,470,664Jul 12 04:46 PM